EFFICACY AND SAFETY OF ABATACEPT IN ACTIVE PRIMARY SJOGREN'S SYNDROME: RESULTS OF A RANDOMISED PLACEBO-CONTROLLED PHASE III TRIAL

被引：13

作者：

Baer, Alan ^{[1
]}

Gottenberg, Jacques-Eric ^{[2
]}

St Clair E, William ^{[3
]}

Sumida, Takayuki ^{[4
]}

Takeuchi, Tsutomu ^{[5
]}

Seror, Raphaele ^{[6
]}

Foulks, Gary ^{[7
]}

Nys, Marleen ^{[8
]}

Johnsen, Alyssa ^{[9
]}

Wong, Robert ^{[9
]}

Ray, Neelanjana ^{[9
]}

Bootsma, Hendrika ^{[10
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[2] Strasbourg Univ Hosp, Strasbourg, France

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Univ Tsukuba, Tsukuba, Ibaraki, Japan

[5] Keio Univ, Sch Med, Tokyo, Japan

[6] Univ Hosp Paris Sud Bicetre, Paris, France

[7] Univ Louisville, Sch Med, Louisville, KY 40292 USA

[8] Bristol Myers Squibb, Braine Lalleud, Belgium

[9] Bristol Myers Squibb, Princeton, NJ USA

[10] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.2090

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0039

引用

页码：89 / 90

页数：2

共 2 条

[1] Evaluation of Histologic, Serologic, and Clinical Changes in Response to Abatacept Treatment of Primary Sjogren's Syndrome: A Pilot Study [J].

Adler, Sabine ;

Koerner, Meike ;

Foerger, Frauke ;

Huscher, Doerte ;

Caversaccio, Marco-Domenico ;

Villiger, Peter M. .

ARTHRITIS CARE & RESEARCH, 2013, 65 (11) :1862-1868

[2] Abatacept treatment reduces disease activity in early primary Sjogren's syndrome (open-label proof of concept ASAP study) [J].

Meiners, P. M. ;

Vissink, A. ;

Kroese, F. G. M. ;

Spijkervet, F. K. L. ;

Smitt-Kamminga, N. Sillevis ;

Abdulahad, W. H. ;

Bulthuis-Kuiper, J. ;

Brouwer, E. ;

Arends, S. ;

Bootsma, H. .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) :1393-1396

← 1 →